Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

4.24
Delayed Data
As of Jul 22
 +0.04 / +0.95%
Today’s Change
3.50
Today|||52-Week Range
15.00
-33.33%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close4.20
Today’s open4.24
Day’s range4.19 - 4.24
Volume7,021
Average volume (3 months)44,702
Market cap$323.4M
Dividend yield--
Data as of 07/22/2016

Growth & Valuation

Earnings growth (last year)-33.20%
Earnings growth (this year)+29.39%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+13.25%
P/E ratio--
Price/Sales54.36
Price/Book0.60

Competitors

 Today’s
change
Today’s
% change
CFMSConforMIS Inc-0.15-2.15%
IVCInvacare Corp-0.13-0.99%
RTIXRTI Surgical Inc+0.06+1.60%
DSCIDerma Sciences Inc+0.02+0.48%
Data as of 07/22/2016

Financials

Next reporting dateAugust 25, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$17.1M
Annual profit (last year)-$99.4M
Net profit margin-582.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, Executive Director &
MD
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts

Partner Offers

Search for Jobs